Leptin suppresses non-apoptotic cell death in ischemic rat cardiomyocytes by reduction of iPLA(2) activity

Biochem Biophys Res Commun. 2015 Jul;463(1-2):13-7. doi: 10.1016/j.bbrc.2015.05.008. Epub 2015 May 13.

Abstract

Caspase-independent, non-apoptotic cell death is an important therapeutic target in myocardial ischemia. Leptin, an adipose-derived hormone, is known to exhibit cytoprotective effects on the ischemic heart, but the mechanisms are poorly understood. In this research, we found that pretreatment of leptin strongly suppressed ischemic-augmented nuclear shrinkage and non-apoptotic cell death on cardiomyocytes. Leptin was also shown to significantly inhibit the activity of iPLA2, which is considered to play crucial roles in non-apoptotic cell death, resulting in effective prevention of ischemia-induced myocyte death. These findings provide the first evidence of a protective mechanism of leptin against ischemia-induced non-apoptotic cardiomyocyte death.

Keywords: Caspase-independence; Ischemia; Leptin; Non-apoptotic cell death; iPLA(2).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Death / drug effects
  • Cell Death / physiology*
  • Cell Hypoxia
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism
  • Cell Nucleus / pathology
  • Cells, Cultured
  • Culture Media, Serum-Free
  • Glucose / administration & dosage
  • Group VI Phospholipases A2 / antagonists & inhibitors
  • Group VI Phospholipases A2 / metabolism*
  • Leptin / administration & dosage
  • Leptin / metabolism*
  • Myocardial Ischemia / metabolism*
  • Myocardial Ischemia / pathology*
  • Myocardial Ischemia / prevention & control
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism*
  • Myocytes, Cardiac / pathology*
  • Rats

Substances

  • Culture Media, Serum-Free
  • Leptin
  • Group VI Phospholipases A2
  • Pla2g6 protein, rat
  • Glucose